Navigation Links
Cerenis Therapeutics In-Licenses Intellectual Property for New Treatment of Aortic Valve Stenosis
Date:2/3/2009

Intellectual property based on breakthrough research from a team led by Dr. Jean-Claude Tardif at the Montreal Heart Institute Research Centre, Canada.

TOULOUSE, France and ANN ARBOR, Mich., Feb. 3 /PRNewswire/ -- Cerenis Therapeutics SA (Cerenis), a privately held pharmaceutical company developing HDL-related compounds for the treatment of cardiovascular and metabolic diseases, today announced that it has in-licensed intellectual property supporting an investigational new treatment of aortic valve stenosis (AVS) based on HDL therapy. This technology is based on the findings of a study led by Jean-Claude Tardif, M.D. at the Montreal Heart Institute Research Centre in Canada.

AVS is characterized by a narrowing of the aortic valve, which can obstruct the flow of oxygenated blood from the heart to the rest of the body. As the heart works harder to compensate for the obstruction, the heart muscle thickens and can cause a potentially dangerous imbalance in blood pressure between the heart and body. Symptoms of severe AVS can include angina and syncope (fainting), and major complications can include heart failure and sudden death. AVS is the most common form of heart valve disease in Western countries, resulting in more than 50,000 aortic valve replacement surgeries each year in the U.S.

In Dr. Tardif's placebo-controlled study in rabbit AVS models, the aortic valve opening in the treatment group returned to a near-normal state and aortic valve thickness was significantly decreased after 14 days of treatment. In addition, the treatment group showed significantly less extensive valve lesions than the control group as well as reduced aortic valve calcification. Results of the study were published in April 2008 in the British Journal of Pharmacology.

"We are very pleased to add this exciting new intellectual property to our growing portfolio of HDL therapies," said Jean-Louis Dasseux, Ph.D.,
'/>"/>

SOURCE Cerenis Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Cerenis Therapeutics Completes Phase I Clinical Trial of CER-002 for Treatment of Cardiovascular Disease
2. PTC Therapeutics Completes Enrollment of Pivotal Trial in Muscular Dystrophy
3. DNA Therapeutics Closes 2.2 Million EUR Series A Financing Round
4. Synvista Therapeutics Announces Termination of Clinical Trials of Alagebrium and SYI-2074 and Provides Business Update
5. Duska Therapeutics Completes Corporate Name Change to Cordex Pharma
6. Phico Therapeutics Receives GBP1 Million Award From the Wellcome Trust to Take Anti-MRSA Nasal Product Through Early Clinical Trials
7. Pixantrone Pre-NDA Communication from FDA Provides Cell Therapeutics Basis to Begin Rolling NDA Submission
8. Cephalon Signs Option Agreement to Acquire Ception Therapeutics
9. Amicus Therapeutics Announces Positive Progress of Three Lead Clinical Programs and General Outlook for 2009
10. Cara Therapeutics Initiates Phase II Proof-Of-Concept Trial of Novel Analgesic in Acute Post-Operative Pain
11. ExonHit Therapeutics Expands Strategic Collaboration With Allergan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... , July 28, 2014 STAAR Surgical ... manufacturer and marketer of implantable lenses and delivery systems ... second quarter results and conference call with investors to ... 30, 2014.  The Company rescheduled the release date and ... funeral services for Hideo Watanabe , President of ...
(Date:7/28/2014)... FRANCISCO, Calif. , July 28, 2014 ... provided an update on the status of the KB001-A ... with Sanofi Pasteur.  KB001-A Collaboration ... an agreement with Sanofi Pasteur to regain all rights ... and licensing agreement entered into in 2010 has been ...
(Date:7/28/2014)... 2014  Serco Inc., a provider of professional, ... been awarded a re-compete contract to support the ... Deployable Medical Systems.  Serco will provide deployable medical ... world-class healthcare to meet warfighter and humanitarian requirements ... The five year contract has a one-year base ...
Breaking Medicine Technology:STAAR Surgical Moves Second Quarter Earnings Release and Conference Call One Day to July 31 2KaloBios Provides Update on KB001-A Partnership and Clinical Status 2KaloBios Provides Update on KB001-A Partnership and Clinical Status 3KaloBios Provides Update on KB001-A Partnership and Clinical Status 4KaloBios Provides Update on KB001-A Partnership and Clinical Status 5KaloBios Provides Update on KB001-A Partnership and Clinical Status 6Serco Awarded $22.7 Million Contract to Support Deployable Medical Systems 2
... 14 SARcode Corporation, a privately-held biotechnology company focused ... (LFA-1) antagonists, today announced that Quinton Oswald has joined ... Mr. Oswald brings significant commercial experience and management expertise ... he served as the Vice President & Business Unit ...
... M.D., a 20-year veteran of the consulting and pharmaceutical ... marketing consulting firm ZS Associates as associate principal. ... "I am excited to work with the ZS ... respond to business challenges posed by their internal and ...
Cached Medicine Technology:Quinton Oswald Named Chief Executive Officer of SARcode Corporation 2Quinton Oswald Named Chief Executive Officer of SARcode Corporation 3ZS Associates Appoints Pharmaceutical Industry Veteran to Serve the Firm's Growing Client Base in Germany 2
(Date:7/28/2014)... 2014 The “Tissue Diagnostics ... Digital pathology & Workflow, Special Staining), Disease ... Non Small Cell Lung Cancer and Others), ... companies, Research Laboratories, Contract Research Organizations and ... BRIC, Japan & RoW) - Trends & ...
(Date:7/28/2014)... “China Surgical Generators Market Outlook ... China Surgical Generators market. The report provides value, ... and average prices (in US dollars) within market ... and Argon Plasma Coagulation Generators. , The report ... for each of these market categories, and global ...
(Date:7/28/2014)... 28, 2014 Camp Soaring Eagle ... camp property in Cornville, AZ. The nonprofit organization, ... with the opportunity to attend medically supervised camps ... The organization offers a variety of programs to ... and life threatening illnesses including: Illness Specific Camping ...
(Date:7/28/2014)... Heights, MI (PRWEB) July 28, 2014 ... UHY, introduces the latest edition of UHY International Business ... provided by our members, on the most current business ... around the world. Issue 29 covers the following topics:, ... growth: Which industry sectors will thrive over the next ...
(Date:7/28/2014)... An estimated 68,000 women and men in the ... cancers – an aggressive form of the disease that ... of the body, such as the lungs, liver, bones, ... of Medicine have developed a compound directed at ... blocking tumor cells from “re-seeding.” Their discovery has been ...
Breaking Medicine News(10 mins):Health News:Advanced Cancer Diagnostics Market Worth $3,924.01 Million by 2018 - New Report by MarketsandMarkets 2Health News:Advanced Cancer Diagnostics Market Worth $3,924.01 Million by 2018 - New Report by MarketsandMarkets 3Health News:Advanced Cancer Diagnostics Market Worth $3,924.01 Million by 2018 - New Report by MarketsandMarkets 4Health News:Advanced Cancer Diagnostics Market Worth $3,924.01 Million by 2018 - New Report by MarketsandMarkets 5Health News:Key Market Data on China Surgical Generators Market to 2020 Report Available at MarketOptimizer.org 2Health News:Key Market Data on China Surgical Generators Market to 2020 Report Available at MarketOptimizer.org 3Health News:Key Market Data on China Surgical Generators Market to 2020 Report Available at MarketOptimizer.org 4Health News:Camp Soaring Eagle Announces New Camp Site 2Health News:Camp Soaring Eagle Announces New Camp Site 3Health News:Uhy International Business Issue 29 Now Available 2Health News:Uhy International Business Issue 29 Now Available 3Health News:Drexel Scientists Develop Compound to Stop Spread of Metastatic Cancer Cells 2Health News:Drexel Scientists Develop Compound to Stop Spread of Metastatic Cancer Cells 3
... the proposal of the Ministry of Health to hike the ... ,"A committee has been set up to review fees charged ... medical sector. This includes the licensing and renewal of licenses ... the medical or health establishments as well," said Dr Ibrahim ...
... Ahmedabad. A man suspected with avian influenza infection ... ,Qadar Abubhai Marghiwala, a 30-year-old resident of ... fever for a week., ,Gujarat's Health Minister ... as primary investigations revealed negative results., ,According ...
... taboo with a study on the mounting violence against women. ... supported with funds from the United Nations Development Fund for ... beaten -- usually by her husband or father. A campaign ... ,In Syria violence against women is usually from ...
... to six times as much sunlight as those with fair ... a new study// . ,Researchers at the Australian ... in the summer sunshine to produce enough Vitamin D whereas ... ,Acceptable levels of sunbathing also depends on geography ...
... people as young as 16 whereas the phenomenon once occurred only ... can escape stress in modern day life. Stress increases glucocorticoid levels. ... hair," Mumbai-based Sonal Shah said. ,"Initially, we used to ... to as low as 16 and 18," Shah told IANS on ...
... A new species that provides the missing evolutionary link between ... onto the land about 375 million years ago//, has been ... a skull, a neck, ribs and parts of the limbs ... ,These fossils, found on Ellesmere Island in Arctic ...
Cached Medicine News:Health News:Stress Can Cause Hair loss at 16 2Health News:Species Linking Fish And Land Animals Found 2Health News:Species Linking Fish And Land Animals Found 3
... Precision Hand Instruments were developed in surgeon's ... while still having an instrument with the ... the fear of the bending or breaking. ... manufactured to conform to the surgeon's hand. ...
... Instruments were developed in surgeon's desire to ... having an instrument with the strength to ... of the bending or breaking. Arthrotek Hand ... conform to the surgeon's hand. This new ...
... Hand Instruments were developed in surgeon's desire ... still having an instrument with the strength ... fear of the bending or breaking. Arthrotek ... to conform to the surgeon's hand. This ...
... Hand Instruments were developed in surgeon's desire ... still having an instrument with the strength ... fear of the bending or breaking. Arthrotek ... to conform to the surgeon's hand. This ...
Medicine Products: